https://www.investors.com/news/technology/dice-stock-catapults-to-record-high-on-eli-lilly-buyout/
0
0
6/20/23 at 8:05pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
31 words
0
Comments
Eli Lilly is adding a new suite of experimental immunology treatments to its pipeline.
You are the first to view
Create an account
or login to join the discussion